News

News

Living with MS
Featured / Jun 07

Living with Multiple Sclerosis (MS) – A disease with 1000 faces

Read More
In Conversation with Zorana Maravic, Digestive Cancers Europe (DiCE)
Featured / Sep 20

How can we build a better tomorrow for cancer patients?

Read More
Featured / Jun 16

International Day of the African Child

June 16 marks The International Day of the African Child.
Read More
Media Release / Jul 25
Applications for proposed first-of-a-kind multiple sclerosis biosimilar natalizumab accepted by US FDA and EMA
Learn More
Media Release / Jul 21
Sandoz Supplemental Biologics License Application accepted by US FDA for biosimilar Hyrimoz® (adalimumab-adaz) high concentration formulation (HCF)
Learn More
Media Release / Jul 19
Novartis delivers continued strong momentum of key growth brands, progress on strategic initiatives and confirms FY’22 Group guidance
Learn More
Media Release / Jun 17
Sandoz Application for proposed biosimilar adalimumab’s high concentration formulation accepted by EMA
Learn More

Quick Links

About Us
Who We Are
Our Work
What We Do

In this section

All News
Read in-depth news about how Sandoz is addressing healthcare needs through recent headlines.
Media Releases
Find announcements about Sandoz products, programs and company updates.
Publications
Read, download and order key company publications including annual and performance reports.
Media Library
Visit the Sandoz media resource center to view and download media resources including documents, images and videos
Stay Up-To-Date
Subscribe to the latest news and updates from Novartis on email, RSS and more.
Media Contacts
Find contacts at Sandoz for media and journalist inquiries.
Site Directory

Sandoz today has a strong presence on all continents and is well represented in all key generics markets, allowing us to remain close to patients, doctors, healthcare providers and business partners everywhere.

Explore